首页> 美国卫生研究院文献>other >R-CHOP radioimmunotherapy and maintenance rituximab in untreated follicular lymphoma (SWOG S0801): a single-arm phase 2 multicentre study

【2h】

R-CHOP radioimmunotherapy and maintenance rituximab in untreated follicular lymphoma (SWOG S0801): a single-arm phase 2 multicentre study

机译：未经治疗的滤泡性淋巴瘤的R-CHOP放射免疫治疗和维持利妥昔单抗（SWOG S0801）：单臂2期多中心研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundDespite an abundance of therapeutic options, advanced stage follicular lymphoma (FL) remains incurable. Further, the ideal sequence and absolute benefit of post-induction therapy is unclear. SWOG0801 was designed to evaluate consolidative radioimmunotherapy and sequential maintenance rituximab following chemoimmunotherapy.

机译：背景尽管有许多治疗选择，晚期滤泡性淋巴瘤（FL）仍无法治愈。此外，诱导后治疗的理想顺序和绝对益处尚不清楚。 SWOG0801旨在评估化学免疫治疗后的联合放射免疫治疗和依托单抗的后续维护。

著录项

期刊名称 other
作者
Paul M Barr; Hongli Li; W Richard Burack; Michael LeBlanc; Sonali M Smith; Ajay K Gopal; Justin D Floyd; Daniel O Persky; Oliver W Press; Richard I Fisher; Jonathan W Friedberg;
展开▼
作者单位

展开▼
年(卷),期 -1(5),3
年度 -1
页码 e102–e108
总页数 15
原文格式 PDF
正文语种
中图分类
关键词
follicular lymphoma radioimmunotherapy rituximab;

机译：滤泡性淋巴瘤;放射免疫疗法;利妥昔单抗;

相似文献

外文文献
中文文献
专利

1. Sequential RCHOP, Radioimmunotherapy and Rituximab Maintenance Improves Early Outcomes in Advanced Stage Follicular Lymphoma: 5 Year Outcomes from SWOG 0801 [J] . Barr Paul M., Li Hongli, Burack Richard, Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：顺序RCHOP，放射免疫疗法和利妥昔单抗维持可提高晚期卵泡淋巴瘤早期结果：5年从SWOG 0801的结果
2. Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus I-131-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016 [J] . Shadman Mazyar, Li Hongli, Rimsza Lisa, Journal of Clinical Oncology . 2018,第7期

机译：用Chop Plus Rituximab或Chop加I-131-Toshosomab治疗后之前未经治疗的卵泡淋巴瘤患者持续出色的结果：III期随机研究阶段的长期随访SWOG-S0016
3. Continued Excellent Outcomes in Previously Untreated Follicular Lymphoma Patients after Treatment with CHOP Plus Rituximab or CHOP Plus (131) Iodine-Tositumomab Long Term Follow-up of Phase III Randomized Study SWOG S0016 [J] . Shadman Mazyar, Li Hongli, Rimsza Lisa, Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：在接受CHOP加利妥昔单抗或CHOP Plus（131）碘-Tositumomab治疗的先前未接受治疗的滤泡性淋巴瘤患者中，其持续优异的结果继续进行III期随机研究SWOG S0016的长期随访
4. An MRM study of EZH2 and its somatic mutations in follicular and diffuse large B cell lymphoma [C] . Annie Moradian, S.-W. Grace Cheng, Damian B. Yap, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2011

机译：EZH2的MRM研究及其卵泡弥漫性大B细胞淋巴瘤
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Rituximab Maintenance Versus Observation After Immunochemotherapy (R-CHOP R-MCP and R-FCM) in Untreated Follicular Lymphoma Patients: A Randomized Trial of the Ostdeutsche Studiengruppe Hämatologie und Onkologie and the German Low-Grade Lymphoma Study Group [O] . Carsten Hirt, Eva Hoster, Michael Unterhalt, 2021

机译：在未处理的滤泡淋巴瘤患者中免疫化学疗法（R-ChecR-MCP和R-FCM）后的rituximab维持与观察结果：Ostdeutsche StudiengruppeHämatologieundonkologie和德国低级淋巴瘤研究组的随机试验
7. R-CHOP, radioimmunotherapy, and maintenance rituximab in untreated follicular lymphoma (SWOG S0801): a single-arm, phase 2, multicentre study [O] . Paul M Barr, Hongli Li, W Richard Burack, 2018

机译：在未处理的卵泡淋巴瘤中的R-Chop，放射免疫疗法和维护Rituximab（Swog S0801）：单臂，第2阶段，多期面研究

R-CHOP radioimmunotherapy and maintenance rituximab in untreated follicular lymphoma (SWOG S0801): a single-arm phase 2 multicentre study

摘要

著录项

相似文献

相关主题

期刊订阅